These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Therapeutic efficacy of phenytoin in recessive dystrophic epidermolysis. A comparison of short- and long-term treatment. Cooper TW; Bauer EA Arch Dermatol; 1984 Apr; 120(4):490-5. PubMed ID: 6703753 [TBL] [Abstract][Full Text] [Related]
8. Positive response to 5HT-2 antagonists in a family affected by epidermolysis bullosa Dowling-Meara type. Tadini G; Ermacora E; Cambiaghi S; Brusasco A; Cavalli R Dermatology; 1993; 186(1):80. PubMed ID: 8435526 [No Abstract] [Full Text] [Related]
9. Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa. Epidermolysis Bullosa Study Group. Caldwell-Brown D; Stern RS; Lin AN; Carter DM N Engl J Med; 1992 Jul; 327(3):163-7. PubMed ID: 1608407 [TBL] [Abstract][Full Text] [Related]
10. Randomized, split-body, single-blinded clinical trial of topical broccoli sprout extract: Assessing the feasibility of its use in keratin-based disorders. Kerns ML; Guss L; Fahey J; Cohen B; Hakim JM; Sung S; Lu RG; Coulombe PA J Am Acad Dermatol; 2017 Mar; 76(3):449-453.e1. PubMed ID: 27889290 [TBL] [Abstract][Full Text] [Related]
11. Phenytoin therapy of recessive dystrophic epidermolysis bullosa. Clinical trial and proposed mechanism of action on collagenase. Bauer EA; Cooper TW; Tucker DR; Esterly NB N Engl J Med; 1980 Oct; 303(14):776-81. PubMed ID: 6251365 [TBL] [Abstract][Full Text] [Related]
12. Epidermolysis bullosa simplex complicated by allergic contact dermatitis caused by a hydrocolloid dressing. Müller S; Kiritsi D Contact Dermatitis; 2017 Mar; 76(3):185-186. PubMed ID: 28220564 [No Abstract] [Full Text] [Related]
13. Tetracycline and epidermolysis bullosa simplex: a double-blind, placebo-controlled, crossover randomized clinical trial. Weiner M; Stein A; Cash S; de Leoz J; Fine JD Br J Dermatol; 2004 Mar; 150(3):613-4. PubMed ID: 15030362 [No Abstract] [Full Text] [Related]
14. Botulinum toxin in the treatment of sweat-worsened foot problems in patients with epidermolysis bullosa simplex and pachyonychia congenita. Swartling C; Karlqvist M; Hymnelius K; Weis J; Vahlquist A Br J Dermatol; 2010 Nov; 163(5):1072-6. PubMed ID: 20618323 [TBL] [Abstract][Full Text] [Related]
15. Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial. Wally V; Hovnanian A; Ly J; Buckova H; Brunner V; Lettner T; Ablinger M; Felder TK; Hofbauer P; Wolkersdorfer M; Lagler FB; Hitzl W; Laimer M; Kitzmüller S; Diem A; Bauer JW J Am Acad Dermatol; 2018 May; 78(5):892-901.e7. PubMed ID: 29410318 [TBL] [Abstract][Full Text] [Related]
16. Phenytoin and junctional epidermolysis bullosa. Armoni M; Schlesinger M; Vardy PA; Metzker A Arch Dermatol; 1985 Feb; 121(2):168-9. PubMed ID: 3977324 [No Abstract] [Full Text] [Related]
18. The use of topical phenytoin for healing of chronic venous ulcerations. Hokkam E; El-Labban G; Shams M; Rifaat S; El-Mezaien M Int J Surg; 2011; 9(4):335-8. PubMed ID: 21338720 [TBL] [Abstract][Full Text] [Related]
19. [The effectiveness of phenytoin in the treatment of epidermolysis bullosa hereditaria dystrophica partim inversa (Gedde-Dahl)]. Bandmann HJ; Perwein E Z Hautkr; 1982 Nov; 57(21):1587-98. PubMed ID: 7148073 [No Abstract] [Full Text] [Related]